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In 2006, Utah and New Mexico health departments in-
vestigated a multistate cluster of Escherichia coli O157:H7. 
A case–control study of 22 case-patients found that con-
suming bagged spinach was signiﬁ  cantly associated with 
illness (p<0.01). The outbreak strain was isolated from 3 
bags of 1 brand of spinach. Nationally, 205 persons were ill 
with the outbreak strain.
O
n September 13, 2006, health ofﬁ  cials from several 
states independently notiﬁ  ed the Centers for Disease 
Control and Prevention (CDC) about clusters of Escheri-
chia coli O157:H7 infections and a suspected association 
with spinach. E. coli O157:H7 expresses 1 of 2 types of 
Shiga toxin and can cause severe gastrointestinal infections 
and hemolytic uremic syndrome (HUS).
A multistate outbreak investigation, involving 26 
states, was initiated on September 14. The US Food and 
Drug Administration (FDA) and CDC advised consumers 
not to eat bagged spinach (1,2). The Utah (UDOH) and 
New Mexico Departments of Health conducted a case-
control study to characterize the outbreak and a laboratory 
investigation to test spinach eaten by case-patients for con-
tamination. This report focuses on the investigation con-
ducted in the 2 states.
The case deﬁ  nition for a laboratory-conﬁ  rmed illness 
was culture-conﬁ  rmed E. coli O157:H7 infection in a Utah 
or New Mexico resident with illness onset during August 1, 
2006–October 1, 2006, and a pattern of Xba EXHX01.0124 
shown by pulsed-ﬁ  eld gel electrophoresis (PFGE). This ur-
gent outbreak investigation did not require institutional re-
view board approval.
The Study
The UDOH Enteric Disease Case Report Form and a 
supplemental CDC questionnaire on spinach consumption 
were administered by local or state public health ofﬁ  cials to 
all participants by telephone. Information collected includ-
ed date of disease onset, symptoms, treatment, community-
based exposures, and a food-item history. Questions referred 
to the 8–10 days before case-patient symptom onset. Case-
patients were ﬁ  rst interviewed 3–23 days after illness onset 
(mean = 11.6 days); follow-up interviews for the question-
naire were completed within 23 days of illness onset.
Two controls per case-patient were matched by sex 
and age group to prevent confounding from potential dif-
ferences in diet (3); age groups were <4 years, 5–12 years, 
13–18 years, 19–64 years, and >65 years. Controls were 
selected by using sequential-digit telephone dialing based 
on the matched case-patient’s telephone number. Controls 
reported no gastrointestinal illness 3 days before and after 
symptom onset date of their matched case-patient. 
Exact matched odds ratios (mOR) and conﬁ  dence in-
tervals (CI) were calculated by using conditional logistic 
regression in SAS 9.1 (SAS Institute, Cary, NC, USA). An 
α of 0.05 was used. No statistical analyses were performed 
for the categories “spinach brand” or “location spinach was 
eaten” because of insufﬁ  cient data and inability to generate 
point estimates; we provide only descriptive evaluations of 
these variables. Only persons who indicated deﬁ  nite ex-
posure to a single brand of spinach were included in the 
evaluation of brand.
The Utah Public Health Laboratories (UPHL) and 
New Mexico Scientiﬁ   c Laboratory Division (NMSLD) 
provided analytic testing services for all clinical and spin-
ach samples. Public health ofﬁ   cials collected spinach 
samples in their original packaging from conﬁ  rmed case-
patients. One spinach sample in New Mexico was frozen; 
all other samples were refrigerated. Modiﬁ  ed FDA Bacte-
rial and Analytical Manual methods were used to recover 
E. coli O157:H7 from both clinical and spinach samples 
(4). UPHL used MacConkey broth and NMSLD used Food 
Emergency Response Network (FERN) broth for enrich-
ment instead of Enterohemorrhagic E. coli Enrichment 
Broth; both laboratories used an additional selective media 
(CHROMagar, CHROMagar, Paris, France). 
The presence of O157 and H7 antigens in clinical and 
spinach samples was conﬁ  rmed with latex agglutination 
typing. UPHL used ProLexLatex Agglutination System 
(Pro-Lab Diagnostics, Austin, TX, USA); NMSLD used 
Oxoid Dryspot E. coli O157 test kit (Oxoid, Cambridge, 
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UK) and DIFCO H7 antiserum (DIFCO Laboratories, De-
troit, MI, USA). All clinical isolates were tested for Shiga 
toxin genes (stx1 and stx2) by PCR. Clinical and spinach 
isolates were tested for Shiga toxin expression with the Pre-
mier EHEC enzymatic immunoassay Shiga-toxin test kit 
(Meridian Diagnostics, Inc., Cincinnati, OH, USA). PFGE 
was performed on E. coli O157:H7 cultures from clinical 
and spinach samples by using standard CDC PulseNet op-
erating procedures (5). PCR testing reagents and protocols 
were provided through the Laboratory Response Network 
(LRN) and FERN. 
Eighteen cases were conﬁ  rmed in Utah and 5 in New 
Mexico. Onset dates ranged from August 22 to September 
11 (Figure). Shiga toxin 2 was detected in stool samples 
from all patients. Demographic, clinical, and food expo-
sure information was available for all patients (Table 1, 2). 
Fifty-seven percent of case-patients were hospitalized, and 
29% experienced HUS (age range 2–60 years). No deaths 
were reported.
Matched analyses were performed on 22 case-patients 
and 44 matched controls. Consumption of bagged spinach 
(mOR = 18.7, 95% CI = 2.8–797.1, p<0.01) was signiﬁ  -
cantly associated with case status (Table 2). Food items 
previously implicated as sources of pathogenic E. coli were 
not signiﬁ  cantly associated with case status.
No patients, versus 6 controls, reported only eating 
spinach at a restaurant; 16 patients and 10 controls reported 
only eating spinach in a private home (Table 2). Washing 
spinach before eating did not signiﬁ  cantly change the odds 
of being a case-patient (Table 2). No study participants re-
ported eating only cooked spinach; therefore, cooking was 
not analyzed. Ten case-patients and 3 controls reported def-
inite exposure to single brands of spinach; only brands A 
and B were reportedly consumed by these patients. Seven 
case-patients and 1 control reported deﬁ  nite exposure to 
brand A; 0 case-patients and 2 controls reported deﬁ  nite 
exposure to brand B (Table 2).
Seven bags of spinach (5 from Utah, 2 from New 
Mexico) were provided by 7 case-patients. Five bags had 
been opened and their contents partially consumed. E. coli 
O157:H7, matching the national outbreak strain, was de-
tected by PCR and culture in 2 Utah spinach bags and the 
New Mexico unfrozen bag. All 3 were open bags of brand 
A baby spinach. Lot codes were available on 2 bags; both 
were packed on August 15, 2006, at the same plant, on the 
same shift, but on different machines.
The 4 bags from which E. coli O157:H7 was not de-
tected were also brand A baby spinach and were packed 
on August 15, 22, 23, and 28, 2006. Two bags that tested 
negative were eaten by case-patients who reported eating 
from multiple bags before illness onset.
Conclusions
Consumption of fresh brand A spinach was associated 
with E. coli O157:H7 infection with both epidemiologic 
and laboratory data. Washing spinach before consumption 
did not affect odds of being a case-patient. Possible rea-
sons for this include 1) E. coli could be internalized into 
the plant structure by entering through the roots (6), and 2) 
bacteria are more likely to adhere to cut surfaces of leafy 
greens (e.g., prepackaged spinach) (7). That no case-pa-
tients reported only eating spinach in a restaurant suggests 
that the source of the contaminated spinach did not supply 
commercial establishments.
The percentage of case-patients in whom HUS devel-
oped (29%) was high when compared with that in prior E. 
coli O157:H7 outbreaks (15%–20%) (8,9). This ﬁ  nding 
is consistent with studies that associate Shiga toxin 2–ex-
pressing E. coli with a higher incidence of HUS (10,11).
Our study was subject to certain limitations. One is 
potential recall bias since controls had a longer time lag 
between consumption and interview and less motivation 
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Table 1. Demographic and clinical information on confirmed 
cases, Escherichia coli O157:H7 spinach-associated outbreak, 
Utah and New Mexico, 2006  
Characteristic No. (%), n = 23
Sex
   M 5 (22)
   F 18 (78)
Age group, y
<4 4 (17)
 5–12 5  (22)
 13–18 1  (4)
 19–64 12  (52)
>65 1 (4)
State of residence
 New  Mexico 5  (22)
 Utah 18  (78)
Clinical outcome
 Bloody  diarrhea 22  (96)
 Hospitalized 13  (57)
  Hemolytic uremic syndrome 7 (29)
Figure. Epidemic curve by date of onset of conﬁ  rmed  cases, 
Escherichia coli O157:H7 spinach-associated outbreak, Utah and 
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to accurately recall what foods they had eaten. However, 
overestimation of the association between spinach con-
sumption and illness is unlikely because more controls re-
ported having eaten spinach than were previously identiﬁ  ed 
in surveys of the general population (12). Analysis of brand 
was limited because of poor recall among all participants. 
The sample size was small, resulting in imprecise effect 
estimates and, in certain cases, an inability to calculate a 
measure of association. Exact ORs were used to partially 
counteract this limitation.
This investigation was conducted in response to a na-
tional outbreak of E. coli O157:H7 infections with match-
ing PFGE patterns among 205 persons in 26 states (13). 
Less than 2 weeks after its initiation, this investigation 
provided laboratory and epidemiologic evidence implicat-
ing spinach. The FDA used these data to focus its ﬁ  eld in-
vestigation and interventions and linked the contaminated 
spinach to samples taken from a stream, cattle manure, and 
feces from wild pigs on ranches in Salinas Valley, Califor-
nia (13). In August 2006, FDA launched a lettuce safety 
initiative to address recurring outbreaks of E. coli O157 
infections (14). After this outbreak, the initiative was ex-
panded to include all leafy greens.
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